The role of group IIF-secreted phospholipase A2 in epidermal homeostasis and hyperplasia

  • Kei Yamamoto
    Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 1
  • Yoshimi Miki
    Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 1
  • Mariko Sato
    Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 1
  • Yoshitaka Taketomi
    Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 1
  • Yasumasa Nishito
    Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 3
  • Choji Taya
    Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 3
  • Kazuaki Muramatsu
    School of Science and Engineering, Tokyo Denki University, Saitama 350-0394, Japan 2
  • Kazutaka Ikeda
    Laboratory for Metabolomics, Institute of Physical and Chemical Research (RIKEN) Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan 4
  • Hiroki Nakanishi
    Research Center for Biosignal, Akita University, Akita 010-8543, Japan 5
  • Ryo Taguchi
    College of Bioscience and Biotechnology, Chubu University, Aichi 487-8501, Japan 6
  • Naotomo Kambe
    Department of Dermatology, Chiba University Graduate School of Medicine, Chiba 260-8677, Japan 7
  • Kenji Kabashima
    Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan 8
  • Gérard Lambeau
    Institut de Pharmacologie Moléculaire et Cellulaire, UMR7275, Centre National de la Recherche Scientifique et Université de Nice-Sophia-Antipolis, 06560 Valbonne, France 9
  • Michael H. Gelb
    Departments of Chemistry and Biochemistry, University of Washington, Seattle, WA 98195 10
  • Makoto Murakami
    Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan 1

この論文をさがす

説明

<jats:p>Epidermal lipids are important for skin homeostasis. However, the entire picture of the roles of lipids, particularly nonceramide lipid species, in epidermal biology still remains obscure. Here, we report that PLA2G2F, a functionally orphan-secreted phospholipase A2 expressed in the suprabasal epidermis, regulates skin homeostasis and hyperplasic disorders. Pla2g2f−/− mice had a fragile stratum corneum and were strikingly protected from psoriasis, contact dermatitis, and skin cancer. Conversely, Pla2g2f-overexpressing transgenic mice displayed psoriasis-like epidermal hyperplasia. Primary keratinocytes from Pla2g2f−/− mice showed defective differentiation and activation. PLA2G2F was induced by calcium or IL-22 in keratinocytes and preferentially hydrolyzed ethanolamine plasmalogen-bearing docosahexaenoic acid secreted from keratinocytes to give rise to unique bioactive lipids (i.e., protectin D1 and 9S-hydroxyoctadecadienoic acid) that were distinct from canonical arachidonate metabolites (prostaglandins and leukotrienes). Ethanolamine lysoplasmalogen, a PLA2G2F-derived marker product, rescued defective activation of Pla2g2f−/− keratinocytes both in vitro and in vivo. Our results highlight PLA2G2F as a previously unrecognized regulator of skin pathophysiology and point to this enzyme as a novel drug target for epidermal-hyperplasic diseases.</jats:p>

収録刊行物

被引用文献 (37)*注記

もっと見る

参考文献 (54)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ